These results suggest that inhibiting a portion of the peroxide removal system—catalase, glutathione reductase, thioredoxin reductase, or peroxiredoxin—may enhance the effectiveness of treatments aimed at increasing oxidative stress within cancer cells. The gene discussed is CAT; the disease is cancer.